We are live on ! Find out more
STRO icon

Sutro Biopharma
STRO

122 hedge funds and large institutions have $118M invested in Sutro Biopharma in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more call options, than puts

Call options by funds: $243K | Put options by funds: $67K

17% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 35

0.12% more ownership

Funds ownership: 7.63% → 7.75% (+0.12%)

6% less funds holding

Funds holding: 130 → 122 (-8)

23% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 30

46% less capital invested

Capital invested by funds: $216M → $118M (-$98.8M)

Holders
122
Holders Change
-8
Holders Change %
-6.15%
% of All Funds
1.61%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
41
Reduced
35
Closed
30
Calls
$243K
Puts
$67K
Net Calls
+$176K
Net Calls Change
+$29K

Top Buyers

Rank Fund Capital Flow
1
VPC
Vestal Point Capital
New York
+$7.85M
2
KCM
Kynam Capital Management
New Jersey
+$4.81M
3
Morgan Stanley
Morgan Stanley
New York
+$3.8M
4
BlackRock
BlackRock
New York
+$1.76M
5
Prudential Financial
Prudential Financial
New Jersey
+$1.3M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.96M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$4.49M
3
EP
Eversept Partners
New York
-$3.5M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$2.85M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$2.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
DAFNA Capital Management
California
$804K +$328K +10,750 +33%
Millennium Management
27
Millennium Management
New York
$746K -$4.96M -162,613 -80%
LPL Financial
28
LPL Financial
California
$667K +$282K +9,233 +34%
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$600K -$338K -11,073 -25%
Two Sigma Investments
30
Two Sigma Investments
New York
$582K -$536K -17,548 -36%
UOC
31
UBS O'Connor
Illinois
$553K -$115K -3,760 -11%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$511K +$271K +8,885 +47%
Fisher Asset Management
33
Fisher Asset Management
Washington
$499K – – –
Charles Schwab
34
Charles Schwab
California
$464K – – –
Bank of New York Mellon
35
Bank of New York Mellon
New York
$400K +$7.88K +258 +1%
SC
36
Shay Capital
New York
$375K +$622K +20,360 New
SSA
37
Schonfeld Strategic Advisors
New York
$362K -$265K -8,680 -31%
BCM
38
Bridgeway Capital Management
Texas
$349K +$276K +9,050 +91%
UBS Group
39
UBS Group
Switzerland
$338K +$54.3K +1,780 +11%
Ameriprise
40
Ameriprise
Minnesota
$332K -$5.59K -183 -1%
AIIC
41
AJU IB Investment Company
South Korea
$322K +$534K +17,500 New
Barclays
42
Barclays
United Kingdom
$292K -$349K -11,421 -42%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$290K -$30.4K -997 -6%
SO
44
STRS Ohio
Ohio
$281K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$277K +$208K +6,824 +83%
PAM
46
Panagora Asset Management
Massachusetts
$262K -$313K -10,262 -42%
Man Group
47
Man Group
United Kingdom
$244K -$96.2K -3,152 -19%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$233K +$22.3K +732 +6%
AQR Capital Management
49
AQR Capital Management
Connecticut
$211K -$644K -21,095 -65%
Bank of America
50
Bank of America
North Carolina
$196K -$69.9K -2,289 -18%
1
2
3 4 5

STRO Hedge Fund Activity: Q4 2024 in Review

122 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q4 2024, worth a combined $118M — down 46% from $216M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of STRO and 23 opened new positions — a net loss of 7 holders — while 35 trimmed existing stakes and 41 added.

The largest buyer was Vestal Point Capital, opening a new position worth an estimated $7.85M. The largest seller was Millennium Management, cutting an estimated $4.96M.

  • 122 institutional investors held Sutro Biopharma (STRO) as of Q4 2024, down from 130 in Q3 2024.
  • Funds reported $118M of Sutro Biopharma stock for Q4 2024, down 46% quarter-over-quarter.
  • 23 funds opened new Sutro Biopharma positions in Q4 2024 and 30 closed out, a net change of -7 holders.
  • The largest Sutro Biopharma buyer in Q4 2024 was Vestal Point Capital, an estimated $7.85M added.
  • The largest Sutro Biopharma seller in Q4 2024 was Millennium Management, an estimated $4.96M sold.

Based on aggregated 13F filings for Q4 2024.